GT200600202AA - Proceso para la síntesis de compuestos orgánicos - Google Patents

Proceso para la síntesis de compuestos orgánicos

Info

Publication number
GT200600202AA
GT200600202AA GT200600202AK GT200600202K GT200600202AA GT 200600202A A GT200600202A A GT 200600202AA GT 200600202A K GT200600202A K GT 200600202AK GT 200600202 K GT200600202 K GT 200600202K GT 200600202A A GT200600202A A GT 200600202AA
Authority
GT
Guatemala
Prior art keywords
synthesis
organic compounds
methyl
bencenamine
pyrimidil
Prior art date
Application number
GT200600202AK
Other languages
English (en)
Spanish (es)
Inventor
Stephan Abel
Murat Acemoglu
Bernhard Erb
Christoph Krell
Joseph Sclafani
Mark Meisenbach
Mahavir Prashad
Wen-Chung Shieh
Song Xue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37149980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT200600202A(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT200600202AA publication Critical patent/GT200600202AA/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
GT200600202AK 2005-06-09 2012-05-17 Proceso para la síntesis de compuestos orgánicos GT200600202AA (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68897605P 2005-06-09 2005-06-09

Publications (1)

Publication Number Publication Date
GT200600202AA true GT200600202AA (es) 2014-06-09

Family

ID=37149980

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600202AK GT200600202AA (es) 2005-06-09 2012-05-17 Proceso para la síntesis de compuestos orgánicos

Country Status (25)

Country Link
US (2) US7781597B2 (enExample)
EP (3) EP2292607B1 (enExample)
JP (2) JP5225078B2 (enExample)
KR (2) KR101249199B1 (enExample)
CN (6) CN102180796A (enExample)
AR (1) AR057056A1 (enExample)
AT (1) ATE540931T1 (enExample)
AU (3) AU2006258050B2 (enExample)
BR (1) BRPI0611683A2 (enExample)
CA (4) CA2833394C (enExample)
DK (2) DK2292607T3 (enExample)
ES (3) ES2380489T3 (enExample)
GT (1) GT200600202AA (enExample)
HU (1) HUE028024T2 (enExample)
IN (2) IN2014DN08588A (enExample)
JO (1) JO2758B1 (enExample)
MX (1) MX2007015609A (enExample)
MY (1) MY146795A (enExample)
PE (3) PE20070109A1 (enExample)
PL (3) PL1896426T3 (enExample)
PT (3) PT2292607E (enExample)
RU (1) RU2446162C2 (enExample)
SI (2) SI2292607T1 (enExample)
TW (1) TWI380981B (enExample)
WO (1) WO2006135640A2 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0508140B1 (pt) 2004-03-05 2015-03-17 Nissan Chemical Ind Ltd Composto benzamida substituída por isoxazolina da fórmula (1); da fórmula (2) substituído por 3,5-bis (aril substituído); da fórmula (4) substituída por alquinibenzeno ou um sal do mesmo; "pesticida, agroquímico, inseticida, parasiticida contendo como ingrediente ativo um ou mais composto benzamida substituída por isoxazolina e sal do mesmo"
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 杜邦股份有限公司 控制無脊椎害蟲之異唑啉
WO2008154528A2 (en) 2007-06-13 2008-12-18 E. I. Du Pont De Nemours And Company Isoxazoline insecticides
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
DK2182945T3 (en) 2007-06-27 2015-11-16 Du Pont PROCEDURE TO COMBAT PESTS WITH ANIMALS
TWI649303B (zh) 2007-08-17 2019-02-01 杜邦股份有限公司 製備４-乙醯基-ｎ-〔２-側氧基-２-〔（２，２，２-三氟乙基）胺基〕乙基〕-１-萘甲醯胺之化合物及方法
US8367584B2 (en) 2007-10-03 2013-02-05 E.I. Du Pont De Nemours And Company Naphthalene isoxazoline compounds for control of invertebrate pests
TW201444787A (zh) 2008-04-09 2014-12-01 Du Pont 製備３-三氟甲基查耳酮（ｃｈａｌｃｏｎｅ）之方法
EP2305667A3 (en) 2008-07-17 2011-05-11 Teva Pharmaceutical Industries Ltd. Nilotinib intermediates and preparation thereof
HRP20120793T1 (hr) 2008-11-05 2012-12-31 Teva Pharmaceutical Industries Ltd. Kristalni oblici nilotinib hci
WO2010060074A1 (en) * 2008-11-24 2010-05-27 Teva Pharmaceutical Industries Ltd. Preparation of nilotinib and intermediates thereof
US20110053968A1 (en) 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
EP2576523B1 (en) 2010-05-27 2016-01-13 E. I. du Pont de Nemours and Company Crystalline form of 4-[5 - [3 -chloro-5 -(trifluoromethyl)phenyl] -4,5 -dihydro-5 -(trifluoromethyl)-3 - isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1- naphthalenecarboxamide
SG11201402765TA (en) 2011-12-30 2014-06-27 Hanmi Pharm Ind Co Ltd THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES
CN102592837B (zh) * 2012-03-12 2014-01-15 河北师范大学 制备超级电容器用四氯合金属季铵盐掺杂聚苯胺电极的方法
CN103694176B (zh) 2014-01-07 2015-02-18 苏州立新制药有限公司 尼洛替尼中间体的制备方法
CN104592122B (zh) * 2014-12-09 2018-01-23 凯莱英医药集团（天津）股份有限公司 3‑(4‑甲基‑1h‑咪唑‑1‑基)‑5‑(三氟甲基)苯胺的制备方法
CN105985293B (zh) * 2015-03-04 2018-04-03 埃斯特维华义制药有限公司 尼洛替尼中间体的制备方法
EP3095782A1 (en) 2015-05-18 2016-11-23 Esteve Química, S.A. New method for preparing 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
CN107201532B (zh) * 2017-05-09 2019-08-27 吉林凯莱英医药化学有限公司 芳香化合物的硝化方法
WO2019130254A1 (en) * 2018-01-01 2019-07-04 Laurus Labs Ltd An improved process for 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl) aniline
CN108530364B (zh) 2018-04-10 2020-01-21 江苏创诺制药有限公司 一种3-(4-甲基-1h-咪唑-1-基)-5-三氟甲基苯胺单盐酸盐的晶型及其应用
TWI787523B (zh) 2018-06-15 2022-12-21 漢達生技醫藥股份有限公司 達沙替尼十二烷基硫酸鹽之結晶
EP3953336A4 (en) * 2019-04-06 2023-05-03 Trinapco, Inc SULFONYLDIAZOLES AND N-(FLUOROSULFONYL)AZOLES AND PROCESS FOR THEIR PRODUCTION
EP3904342A1 (en) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride
CN114751836B (zh) * 2021-02-23 2024-05-31 四川青木制药有限公司 3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺合成方法及其中间体
CN114853734A (zh) * 2022-06-14 2022-08-05 海南鑫开源医药科技有限公司 一种尼洛替尼游离碱的制备方法
CN116478319B (zh) * 2022-11-07 2025-07-01 华北电力大学 一种离子共价有机聚合物的制备方法及其在碱性环境吸附ReO4-的应用
CN115626880B (zh) * 2022-11-15 2023-11-14 常州大学 3-硝基-5-氰基三氟甲苯的合成方法
CN118108670B (zh) * 2023-12-28 2025-07-01 江苏希迪制药有限公司 尼罗替尼中间体3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺的精制纯化方法
CN121517361A (zh) * 2026-01-15 2026-02-13 湖南阿斯迪康药业有限公司 一种基于溴苯类化合物合成1-芳基咪唑类化合物的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1051076A1 (ru) * 1982-04-09 1983-10-30 Алтайский политехнический институт Способ получени производных имидазола
PT80533B (en) * 1984-05-29 1987-04-06 Pfizer Process for preparing quinolone inotropic agents
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
GB0023383D0 (en) * 2000-09-23 2000-11-08 Synprotec Ltd 3,5-Bis (Trifluormethyl)Benzene derivatives
PE20040522A1 (es) * 2002-05-29 2004-09-28 Novartis Ag Derivados de diarilurea dependientes de la cinasa de proteina
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
GB0222514D0 (en) * 2002-09-27 2002-11-06 Novartis Ag Organic compounds
CN1939910A (zh) * 2004-12-31 2007-04-04 孙飘扬 氨基嘧啶类化合物及其盐和其制备方法与药物用途
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
GT200600207A (es) * 2005-06-09 2007-01-15 Novartis Ag Proceso para la síntesis de compuestos orgánicos

Also Published As

Publication number Publication date
KR20080014010A (ko) 2008-02-13
AR057056A1 (es) 2007-11-14
ES2558696T3 (es) 2016-02-08
ES2465522T3 (es) 2014-06-06
PE20070109A1 (es) 2007-04-02
PL1896426T3 (pl) 2012-06-29
US20080200692A1 (en) 2008-08-21
TWI380981B (zh) 2013-01-01
EP1896426B1 (en) 2012-01-11
MX2007015609A (es) 2008-02-25
SI2266961T1 (sl) 2016-02-29
US8008504B2 (en) 2011-08-30
WO2006135640A3 (en) 2007-08-02
BRPI0611683A2 (pt) 2010-09-28
EP2292607A3 (en) 2011-04-27
RU2446162C2 (ru) 2012-03-27
AU2010241374B2 (en) 2011-11-03
PL2292607T3 (pl) 2014-09-30
PT1896426E (pt) 2012-04-12
ES2380489T8 (es) 2012-06-22
TW200716563A (en) 2007-05-01
AU2011201044A1 (en) 2011-03-31
CN102174020A (zh) 2011-09-07
PT2292607E (pt) 2014-06-24
PE20100715A1 (es) 2010-10-25
CN102174019A (zh) 2011-09-07
US20100280257A1 (en) 2010-11-04
ES2380489T3 (es) 2012-05-14
AU2006258050A1 (en) 2006-12-21
DK2292607T3 (da) 2014-06-30
EP2266961A3 (en) 2011-07-27
EP1896426A2 (en) 2008-03-12
JP2008546645A (ja) 2008-12-25
EP2292607B1 (en) 2014-04-09
CA2611280C (en) 2014-01-28
RU2007148238A (ru) 2009-07-20
ATE540931T1 (de) 2012-01-15
KR101283109B1 (ko) 2013-07-05
PE20100716A1 (es) 2010-10-25
CN102174019B (zh) 2013-02-13
HUE028024T2 (en) 2016-11-28
US7781597B2 (en) 2010-08-24
JP2013035855A (ja) 2013-02-21
IN2014DN08588A (enExample) 2015-07-10
PT2266961E (pt) 2016-02-05
DK2266961T3 (en) 2016-01-25
MY146795A (en) 2012-09-28
CN102180836B (zh) 2012-11-21
CN102174020B (zh) 2012-11-07
JP5225078B2 (ja) 2013-07-03
EP2266961B1 (en) 2015-10-21
CN102174021B (zh) 2013-02-27
CA2833394C (en) 2016-03-29
CA2942046A1 (en) 2006-12-21
CA2886482A1 (en) 2006-12-21
KR20120099028A (ko) 2012-09-06
CA2886482C (en) 2017-09-05
CN102174021A (zh) 2011-09-07
EP2292607A2 (en) 2011-03-09
CN102180796A (zh) 2011-09-14
CN102180836A (zh) 2011-09-14
JO2758B1 (en) 2014-03-15
CA2611280A1 (en) 2006-12-21
AU2010241374A1 (en) 2010-12-02
CN101189212B (zh) 2011-05-18
EP2266961A2 (en) 2010-12-29
CA2833394A1 (en) 2006-12-21
PL2266961T3 (pl) 2016-04-29
SI2292607T1 (sl) 2014-09-30
KR101249199B1 (ko) 2013-04-03
CN101189212A (zh) 2008-05-28
IN2014DN08578A (enExample) 2015-07-10
AU2006258050B2 (en) 2010-12-09
WO2006135640A2 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
JO2758B1 (en) Process for synthesis of organic compounds
SV2011003809A (es) Derivados de heteroarilo como inhibidores de dgat1
CR9830A (es) Compuestos de amino-5-[4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de la b-secretasa
ATE555105T1 (de) Heterocyclische fxr-bindende verbindungen
CR9331A (es) Inhibidores de vegf-r2 y metodos
DOP2011000113A (es) Pirazolilaminopiridinas como inhibidores de fak
CR9244A (es) AMINO-IMIDAZOLONAS PARA LA INHIBICION DE ß-SECRETASA
PA8772701A1 (es) "COMPUESTOS AMINO-5-[-4-(DIFLUOROMETOXI)FENIL SUSTITUIDO)-5-FENILIMIDAZOLONA COMO INHIBIDORES DE ß-SECRETASA"
MX2008002293A (es) Uso novedoso de compuestos peptidicos para tratar dolor muscular.
MX2009006846A (es) Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias.
EA200900798A1 (ru) Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы
GT200800242A (es) Derivados biciclicos como inhibidores de cetp
CO6382129A2 (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o provencion de diabetes
MX358961B (es) Compuestos de tetraciclina sustituidos con fluor en c7.
GT200600327A (es) Ciclohexilaminoisoquinolona
CR9272A (es) Amino-imidazolonas para la inhibicion de b-secretasa
NO20085029L (no) Substituerte pyridylamidforbindelser som modulatorer av histamin H3 reseptoren
NO20081685L (no) Fremgangsmate for fremstilling oksazolidin-beskyttelse aminodolforbindelser anvendbare som mellomprodukter for Florfenicol
PA8666701A1 (es) Nueva sal y polimorfos del inhibidor de la dpp-iv
HN2010000313A (es) Pirimidinas biciclicas fusionadas
MX2010004669A (es) Proceso para la preparacion de derivados de isoindol asi como tambien un proceso para la preparacion de sus intermediarios.
UY30778A1 (es) Compuestos de 5,6-dihidro-1h-piridin-2-ona
ATE517869T1 (de) Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
CU23820A3 (es) (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y procedimiento de obtención
NO20090234L (no) Tricyklisk sammensetning og farmasoytisk anvendelse derav